MRANK-101

N/A

Report date: 2024/09/20 09:28:16

NME

Base Information

Drug NameMRANK-101

Drug Alias NameMRANK-101

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor protein p53 modulators

TargetsTumor protein p53

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesMindRank Ltd

China Registration ClassN/A

Active CompaniesMindRank Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A